Get the Stockscreener App
3.4286
0.91%
-0.0314
Heartsciences Inc stock is traded at $3.4286, with a volume of 4,780.
It is down -0.91% in the last 24 hours and up +12.41% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.46
Open:
$3.4899
24h Volume:
4,780
Relative Volume:
0.32
Market Cap:
$3.89M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1407
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
-4.76%
1M Performance:
+12.41%
6M Performance:
+28.41%
1Y Performance:
-61.86%
1-Day Range:
$3.42
$3.4899
1-Week Range:
$3.38
$3.6202
52-Week Range:
$2.36
$13.50
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.4286 | 3.89M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Heartsciences Inc Stock (HSCS) Latest News
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025Featuring CEO Andrew Simpson - The Manila Times
HeartSciences (HSCS) Enhances Team with Key Scientific Advisory Appointments | HSCS Stock News - GuruFocus
HeartSciences Inc. Expands Scientific Advisory Board with Three New Appointments to Enhance AI-Driven Cardiac Care - Nasdaq
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - The Manila Times
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
HeartSciences launches MyoVista Insights platform - TipRanks
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS S - GuruFocus
HeartSciences (HSCS) Unveils MyoVista Insights Platform | HSCS Stock News - GuruFocus
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - The Manila Times
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Northstar Secures 15-Year Lease Extension For Delta, BC Facility - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
HeartSciences Q3: AI-ECG Breakthrough Nears FDA Milestone as CMS Backs Reimbursement - StockTitan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - The Manila Times
AI Medical Tech Firm HeartSciences Strengthens Investor Communications Strategy - StockTitan
HeartSciences grants stock options to executives and directors - MSN
HeartSciences grants stock options to executives and directors By Investing.com - Investing.com South Africa
Becton, Dickinson And Company's Q1 2025 Earnings: What To Expect - Barchart.com
Scientists Discover Heart-Saving Powers in Olive, Grape, Garlic, Rosemary, and Saffron - SciTechDaily
HeartSciences Inc. withdraws IPO registration - Investing.com
HeartSciences Inc. withdraws IPO registration By Investing.com - Investing.com UK
Biogen Stock: Is BIIB Underperforming The Healthcare Sector? - Barchart.com
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Advances AI-Powered ECG Platform, FDA Submission Set for Q1 2025 - StockTitan
Anteris Technologies Prices $88.8M Nasdaq IPO for Revolutionary Heart Valve Development - StockTitan
Bill Otten Joins Hello Heart as Commercial President - Medical Product Outsourcing
David Chung Lands Top Job at Heart Repair Technologies - Medical Product Outsourcing
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCSW Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Clear Secure: Q3 Earnings Snapshot - Barchart.com
Investor Alert: Halo Collective, Inc. And Its Missing Continuous Disclosure Documents - Barchart.com
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
What To Expect From Pfizer's Q3 2024 Earnings Report - Barchart.com
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Earnings Preview: What To Expect From Intuitive Surgical's Report - Barchart.com
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire
HSCSHeartSciences Inc Latest Stock News & Market Updates - Stock Titan
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):